Dr. Eunice Van Den Berg

Eunice Van Den Berg is a South African clinician‑scientist whose work centers on breast cancer biology and pathology in sub‑Saharan Africa. Her research integrates molecular profiling, immunohistochemistry, and health systems evaluation to improve diagnostic accuracy and treatment stratification in resource‑limited settings. She is closely involved in collaborative cohort studies that address disparities in outcomes across diverse populations.

Her publications highlight the application of PAM50 intrinsic subtyping, risk of recurrence assessment, and Ki67 evaluation in South African cohorts, including women living with HIV. She has examined discordance between genomic assays and routine immunohistochemistry, proposing context‑appropriate refinements to enhance clinical decision‑making. Additional work on tumor microenvironment diversity and FGFR2 variants underscores a commitment to understanding population‑specific tumor biology.

Beyond oncology, Van Den Berg has contributed to studies on opportunistic infections in advanced HIV, including invasive fungal disease and rare viral or parasitic presentations, reflecting broad expertise in diagnostic pathology and infectious disease. Collectively, her scholarship advances precision oncology and strengthens pathology standards in the African context.